The NIH said that while the anti-malarial drug did not cause harm to patients in the study, testing showed little evidence that it would benefit patients hospitalized with COVID-19.
Copyright 2020 NPR
© 2023
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations